![ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/.imaging/default/dam/Marketing/AltuviiioUS/altuviiio.webp/jcr:content.webp)
Join us at an upcoming event
Connect with the hemophilia community
CelebrVIII with ALTUVIIIO®
Join us for a celebration!
- Hear from and talk to Peer speakers about their experiences with ALTUVIIIO
- Participate in an activity
- Meet others in the community
- And more!
Reach out to your local CoRe to learn how you can attend a CelebrVIII event.
Hemophilia Federation of American (HFA) Annual Symposium
-
April 16-19, 2026
-
New Orleans Marriott Hotel | New Orleans, Louisiana
-
Booth TBD
Texas Bleeding Disorders Conference (TBDC)
-
June 12-14, 2026
-
JW Marriott Hotel | Austin, Texas
Pennsylvania Bleeding Disorders Conference
-
Date: TBD
-
Location: TBD
This event is open to members of the Western or Eastern PA Bleeding Disorders Foundations or patients of one of the seven HTCs in PA. Registration is limited to immediate family members living in the household with the person who has a bleeding disorder. To request a registration form, send an email to rsvp@wpbdf.org or call 724-741-6160. Once approved, you
will receive a link to fill out your registration form online.
National Bleeding Disorders Foundation’s (NBDF) Bleeding
Disorders Conference (BDC)
-
August 13-15, 2026
-
Orlando World Center Marriott | Orlando, Florida
-
Join our lunch symposium on Saturday, August 15 at 12:30 PM – 1:30 PM! A healthcare professional and CoRe will highlight the benefits and safety of ALTUVIIIO and detail real-world patient case studies
Unless otherwise noted, Sanofi, the host of this industry-sponsored educational symposium/ networking event, is solely responsible for its content, including any information presented or distributed during the event. The National Bleeding Disorders Foundation does not endorse any particular treatment products or manufacturers; any reference to a product name is not an endorsement by NBDF. NBDF is not a regulatory agency and cannot make recommendations relating to the safety of manufacturing of specific treatment products. For recommendations of a particular product, the regulatory authority in a particular country must make these judgments based on domestic legislation and national health policies.
Hope Conference
-
November 5-7, 2026
-
Orlando, Florida
Find your CoRe Manager and connect today!
Sanofi Hemophilia Community Relations and Education (CoRe) Managers offer education to
people living with hemophilia and their families. CoRe Managers provide information about
living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe
team member nearest you.
ALTUVIIIO® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Your healthcare provider may give you ALTUVIIIO when you have surgery.
What is the most important information I need to know about ALTUVIIIO?
Do not attempt to give yourself an injection unless you have been taught how by your healthcare provider or hemophilia center. You must carefully follow your healthcare provider’s instructions regarding the dose and schedule for injecting ALTUVIIIO so that your treatment will work best for you.
Who should not use ALTUVIIIO?
You should not use ALTUVIIIO if you have had an allergic reaction to it in the past.
What should I tell my healthcare provider before using ALTUVIIIO?
Tell your healthcare provider if you have had any medical problems, take any medications, including prescription and non-prescription medicines, supplements, or herbal medicines, are breastfeeding, or are pregnant or planning to become pregnant.
What are the possible side effects of ALTUVIIIO?
You can have an allergic reaction to ALTUVIIIO. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called “inhibitors” against ALTUVIIIO. This can stop ALTUVIIIO from working properly. Your healthcare provider may give you blood tests to check for inhibitors.
The common side effects of ALTUVIIIO are headache and joint pain.
These are not the only possible side effects of ALTUVIIIO. Tell your healthcare provider about any side effect that bothers you or does not go away.
Please see full Prescribing Information.
Learn more about Sanofi’s commitment to fighting counterfeit drugs.
![ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/dam/jcr:0bd6aa08-1390-4c29-8440-7d6809e35b97/Altuviiio.svg)